188 related articles for article (PubMed ID: 28488812)
1. Decreased body mass index is associated with impaired survival in lung cancer patients with brain metastases: A retrospective analysis of 624 patients.
Masel EK; Berghoff AS; Füreder LM; Heicappell P; Schlieter F; Widhalm G; Gatterbauer B; Dieckmann U; Birner P; Bartsch R; Schur S; Watzke HH; Zielinski CC; Preusser M
Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 28488812
[TBL] [Abstract][Full Text] [Related]
2. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
3. Prognostic assessment in patients with newly diagnosed small cell lung cancer brain metastases: results from a real-life cohort.
Steindl A; Schlieter F; Klikovits T; Leber E; Gatterbauer B; Frischer JM; Dieckmann K; Widhalm G; Zöchbauer-Müller S; Hoda MAR; Preusser M; Berghoff AS
J Neurooncol; 2019 Oct; 145(1):85-95. PubMed ID: 31456143
[TBL] [Abstract][Full Text] [Related]
4. Effect of body mass index on survival of patients with stage I non-small cell lung cancer.
Xie HJ; Zhang X; Wei ZQ; Long H; Rong TH; Su XD
Chin J Cancer; 2017 Jan; 36(1):7. PubMed ID: 28069048
[TBL] [Abstract][Full Text] [Related]
5. Impact of non-small cell lung cancer histology on survival predicted from the graded prognostic assessment for patients with brain metastases.
Guo S; Reddy CA; Chao ST; Suh JH; Barnett GH; Vogelbaum MA; Videtic GM
Lung Cancer; 2012 Aug; 77(2):389-93. PubMed ID: 22542706
[TBL] [Abstract][Full Text] [Related]
6. Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer.
Kaul D; Angelidis A; Budach V; Ghadjar P; Kufeld M; Badakhshi H
Radiat Oncol; 2015 Nov; 10():244. PubMed ID: 26611493
[TBL] [Abstract][Full Text] [Related]
7. Body Mass Index (BMI), BMI Change, and Overall Survival in Patients With SCLC and NSCLC: A Pooled Analysis of the International Lung Cancer Consortium.
Shepshelovich D; Xu W; Lu L; Fares A; Yang P; Christiani D; Zhang J; Shiraishi K; Ryan BM; Chen C; Schwartz AG; Tardon A; Wu X; Schabath MB; Teare MD; Le Marchand L; Zhang ZF; Field JK; Brenner H; Diao N; Xie J; Kohno T; Harris CC; Wenzlaff AS; Fernandez-Tardon G; Ye Y; Taylor F; Wilkens LR; Davies M; Liu Y; Barnett MJ; Goodman GE; Morgenstern H; Holleczek B; Brown MC; Liu G; Hung RJ
J Thorac Oncol; 2019 Sep; 14(9):1594-1607. PubMed ID: 31163278
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of body mass index and change in body weight in postoperative outcomes of lung cancer surgery.
Nakagawa T; Toyazaki T; Chiba N; Ueda Y; Gotoh M
Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):560-6. PubMed ID: 27252238
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of body mass index and prognostic nutritional index in stage II/III gastric cancer.
Park SH; Lee S; Song JH; Choi S; Cho M; Kwon IG; Son T; Kim HI; Cheong JH; Hyung WJ; Choi SH; Noh SH; Choi YY
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):620-625. PubMed ID: 31668977
[TBL] [Abstract][Full Text] [Related]
10. Down-regulated microRNA-375 expression as a predictive biomarker in non-small cell lung cancer brain metastasis and its prognostic significance.
Chen LJ; Li XY; Zhao YQ; Liu WJ; Wu HJ; Liu J; Mu XQ; Wu HB
Pathol Res Pract; 2017 Aug; 213(8):882-888. PubMed ID: 28688608
[TBL] [Abstract][Full Text] [Related]
11. The effect of non-small cell lung cancer histology on survival as measured by the graded prognostic assessment in patients with brain metastases treated by hypofractionated stereotactic radiotherapy.
Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L
Radiat Oncol; 2016 Jul; 11():92. PubMed ID: 27411944
[TBL] [Abstract][Full Text] [Related]
12. Association of body mass index and outcomes following lobectomy for non-small-cell lung cancer.
Wang C; Guo M; Zhang N; Wang G
World J Surg Oncol; 2018 May; 16(1):90. PubMed ID: 29751759
[TBL] [Abstract][Full Text] [Related]
13. Prediagnosis weight loss, a stronger factor than BMI, to predict survival in patients with lung cancer.
Morel H; Raynard B; d'Arlhac M; Hauss PA; Lecuyer E; Oliviero G; Marty C; Gury JP; Asselain B; Grivaux M; Debieuvre D
Lung Cancer; 2018 Dec; 126():55-63. PubMed ID: 30527193
[TBL] [Abstract][Full Text] [Related]
14. Body mass index as a prognostic factor in epithelial ovarian cancer and correlation with clinico-pathological factors.
Skírnisdóttir I; Sorbe B
Acta Obstet Gynecol Scand; 2010; 89(1):101-7. PubMed ID: 19878086
[TBL] [Abstract][Full Text] [Related]
15. Statins use and risk for brain metastasis from lung cancer.
Leigh D; Eken J; Beal JR; Ganti AK; Sahmoun AE
Cancer Invest; 2011 Jan; 29(1):68-72. PubMed ID: 20873993
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of patient gender in limited-disease small-cell lung cancer treated with chemoradiotherapy.
Roengvoraphoj O; Eze C; Niyazi M; Li M; Hildebrandt G; Fietkau R; Belka C; Manapov F
Strahlenther Onkol; 2017 Feb; 193(2):150-155. PubMed ID: 27853828
[TBL] [Abstract][Full Text] [Related]
17. Obesity is associated with long-term improved survival in definitively treated locally advanced non-small cell lung cancer (NSCLC).
Lam VK; Bentzen SM; Mohindra P; Nichols EM; Bhooshan N; Vyfhuis M; Scilla KA; Feigenberg SJ; Edelman MJ; Feliciano JL
Lung Cancer; 2017 Feb; 104():52-57. PubMed ID: 28213000
[TBL] [Abstract][Full Text] [Related]
18. Overweight is associated with improved survival and outcomes in patients with atrial fibrillation.
Wang J; Yang YM; Zhu J; Zhang H; Shao XH; Tian L; Huang B; Yu LT; Gao X; Wang M
Clin Res Cardiol; 2014 Jul; 103(7):533-42. PubMed ID: 24535378
[TBL] [Abstract][Full Text] [Related]
19. Body mass index does not affect the survival of pancreatic cancer patients.
Jiang QL; Wang CF; Tian YT; Huang H; Zhang SS; Zhao DB; Ma J; Yuan W; Sun YM; Che X; Zhang JW; Chu YM; Zhang YW; Chen YT
World J Gastroenterol; 2017 Sep; 23(34):6287-6293. PubMed ID: 28974895
[TBL] [Abstract][Full Text] [Related]
20. Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer.
Dudek AZ; Kmak KL; Koopmeiners J; Keshtgarpour M
Lung Cancer; 2006 Jan; 51(1):89-96. PubMed ID: 16290256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
